International consensus (ICON) on assessment of oropharyngeal dysphagia

Espitalier, F.; Fanous, Ayman H.; Aviv, Jonathan E.; Bassiouny, S.; Desuter, Gauthier; Nerurkar, N.; Postma, Gregory; Crevier‐Buchman, Lise

doi:10.1016/j.anorl.2017.12.009

Cited by 36 publications

(38 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…23 A main weakness of FEES is the overestimation of the quantity of pharynx residue, which can be corrected by complementary videofluoroscopy analysis. 26 We found that bolus consistency affected FEES outcomes in patients with DM1 and in presymptomatic carriers to a similar extent, with more severe impairment when swallowing liquids than when swallowing solids. Specifically, scores for delayed pharyngeal reflex and postswallow residue were similar between the 2 groups.…”

Section: Discussionmentioning

confidence: 59%

“…Fiberoptic‐endoscopic evaluation is a routine technique to detect the presence and location of postswallow residue, penetration, and aspiration . Furthermore, FEES does not require exposure to radiation, can be repeated as often as required, and allows acquisition of high‐resolution axial endoscopy images . A main weakness of FEES is the overestimation of the quantity of pharynx residue, which can be corrected by complementary videofluoroscopy analysis …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Oropharyngeal dysphagia in early stages of myotonic dystrophy type 1

et al. 2019

View full text Add to dashboard Cite

Introduction Myotonic dystrophy type 1 (DM1) is a multisystemic disorder characterized mainly by skeletal muscle alterations. Although oropharyngeal dysphagia is a prominent clinical feature of DM1, it remains poorly studied in its early disease stages. Methods Dysphagia was investigated in 11 presymptomatic DM1 carriers, 14 patients with DM1 and 12 age‐matched healthy controls, by using fiberoptic endoscopic evaluation of swallowing (FEES) and clinical scores. Results Scores for the FEES variables, delayed pharyngeal reflex, posterior pooling, and postswallow residue were significantly greater in patients with DM1 and in presymptomatic DM1 carriers than in healthy controls (P < 0.05); oropharyngeal dysfunction was more severe in patients than in presymptomatic carriers. Penetration/aspiration was found altered exclusively in patients with DM1 (P < 0.05). Discussion Swallowing dysfunction occurs in presymptomatic DM1 carriers. Timely diagnosis of dysphagia in preclinical stages of the disease will aid in the timely management of presymptomatic carriers, potentially preventing medical complications. Muscle Nerve, 2019

show abstract

Section: Discussionmentioning

confidence: 59%

Section: Discussionmentioning

confidence: 99%

Oropharyngeal dysphagia in early stages of myotonic dystrophy type 1

et al. 2019

View full text Add to dashboard Cite

show abstract

“…This disparity was already found in prior reviews of swallowing assessment in other diseases. 20,31,32,68,69 In addition, previous studies reported poor inter-rater reliability for VFSS, depending on the procedure and bolus consistency used to assess swallowing in adult patients. 70,71 Equally, five reviews in non-NMD adult patients emphasized that consensus on the terminology and study protocols (e.g.…”

Section: Discussionmentioning

confidence: 99%

Screening and evaluation tools of dysphagia in adults with neuromuscular diseases: a systematic review

Audag

Goubau

Toussaint³

et al. 2019

Therapeutic Advances in Chronic Disease

View full text Add to dashboard Cite

Background:The purpose of this systematic review was to summarize the different dysphagia screening and evaluation tools, and to identify their measurement properties in adults with neuromuscular diseases (NMDs).Methods:A systematic review was performed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The search strategy was conducted across three databases (PubMed, CINAHL and ScienceDirect). Measurement properties of each tools and the Quality Index, developed by Downs and Black, were considered for the different investigated studies.Results:The search strategy produced 2221 articles. After removal of duplicates and full-text analysis, 19 studies were included. Most of the publications focused on amyotrophic lateral sclerosis (ALS; n = 10) and Duchenne muscular dystrophy (DMD; n = 4). A total of 12 tools, listed as instrumental and noninstrumental examinations, were retrieved. A total of five of them used videofluoroscopic swallow study (VFSS). Measurement properties of the tools are not completely described in detail in many studies. The neuromuscular disease swallowing status scale, a noninstrumental tool, is the only one that assessed all measurement properties in ALS patients. The median score reported for the Quality Index was 16.Conclusions:This systematic review identified 12 different tools for the screening and evaluation of dysphagia in adults with NMD. Majority of the studies presented VFSS as a valid and reliable examination to assess dysphagia in ALS and DMD. Other tools were mainly evaluated in ALS patients, but further studies are needed to complete their measurement properties. In other NMDs, no firm conclusion can be made because of insufficient data and heterogeneity of NMDs.

show abstract

“…Both surgical and non-surgical treatment of HNC can result in transient or permanent OD as described in "Pathophysiology and mechanisms of oropharyngeal dysphagia" section [178]. OD puts the patient not only at risk for aspiration pneumonia, malnutrition, dehydration, and choking, which all increase morbidity but also for reduced QOL [180]. Incidence, diagnosis, and management of malnutrition and dehydration are described in further detail in "Cancer cachexia in head and neck cancer" and "Treatment of cancer cachexia" sections.…”

Section: Complications Due To Oropharyngeal Dysphagia In Head and Necmentioning

confidence: 99%

European white paper: oropharyngeal dysphagia in head and neck cancer

Baijens

Walshe

Aaltonen

et al. 2020

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Purpose To develop a European White Paper document on oropharyngeal dysphagia (OD) in head and neck cancer (HNC). There are wide variations in the management of OD associated with HNC across Europe. Methods Experts in the management of specific aspects of OD in HNC across Europe were delegated by their professional medical and multidisciplinary societies to contribute to this document. Evidence is based on systematic reviews, consensus-based position statements, and expert opinion. Results Twenty-four sections on HNC-specific OD topics. Conclusion This European White Paper summarizes current best practice on management of OD in HNC, providing recommendations to support patients and health professionals. The body of literature and its level of evidence on diagnostics and treatment for OD in HNC remain poor. This is in the context of an expected increase in the prevalence of OD due to HNC in the near future. Contributing factors to increased prevalence include aging of our European population (including HNC patients) and an increase in human papillomavirus (HPV) related cancer, despite the introduction of HPV vaccination in various countries. We recommend timely implementation of OD screening in HNC patients while emphasizing the need for robust scientific research on the treatment of OD in HNC. Meanwhile, its management remains a challenge for European professional associations and policymakers.

show abstract

International consensus (ICON) on assessment of oropharyngeal dysphagia

Cited by 36 publications

References 24 publications

Oropharyngeal dysphagia in early stages of myotonic dystrophy type 1

Oropharyngeal dysphagia in early stages of myotonic dystrophy type 1

Screening and evaluation tools of dysphagia in adults with neuromuscular diseases: a systematic review

European white paper: oropharyngeal dysphagia in head and neck cancer

Contact Info

Product

Resources

About